FundedAndHiringPulse / compare
BioLattice Ophthalmics, Inc, vs Telemachus Therapeutics, Inc.: FundedAndHiringPulse comparison
BioLattice Ophthalmics, Inc,'s offering of 3,310,000 is 2.2x Telemachus Therapeutics, Inc.'s 1,500,000 (36th percentile). BioLattice Ophthalmics, Inc, is dated 2026-10-28; Telemachus Therapeutics, Inc. 2026-10-28.
Data as of · Compiled by Zalwin from SEC EDGAR Form D via FormDPulse (operating companies only, no individuals)
Both records plus every comparable PA record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BioLattice Ophthalmics, Inc, compare to Telemachus Therapeutics, Inc.?
| Field | BioLattice Ophthalmics, Inc, | Telemachus Therapeutics, Inc. |
|---|---|---|
| Company | BioLattice Ophthalmics, Inc, | Telemachus Therapeutics, Inc. |
| Location | Philadelphia, PA | Wexford, PA |
| Industry | Biotechnology | Pharmaceuticals |
| Likely hiring | Healthcare and life sciences (clinical, R&D) | Healthcare and life sciences (clinical, R&D) |
| Offering | $3,310,000 | $1,500,000 |
| Sold so far | $1,825,000 | $375,000 |
| Filed | 2026-10-28 (7 days ago) | 2026-10-28 (7 days ago) |
| Incorporated | 2023 | 2026 |
| Revenue range | Decline to Disclose | Decline to Disclose |
| Next steps | Find the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page. | Find the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page. |
| amount percentile | 36th | 16th |
| Scaling Signal Score | 85/100 | 75/100 |
| Peer rank and all 4 PA records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BioLattice Ophthalmics, Inc, · Telemachus Therapeutics, Inc.
Get new funded companies in your niche every week
FundedAndHiringPulse can email you new filers matching your states, hiring classes and raise sizes.
Built from SEC Form D filings, which report an offering, not a hiring plan; "likely to hire" is our classification from industry and raise size, not a statement by the company. Filings can be amended or withdrawn; confirm on SEC EDGAR. Companies only; individuals named in filings are not included. Not a consumer report and may not be used for FCRA purposes. Not investment advice.